Aimei Health Technology Co., Ltd (AFJK) Research
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
Market snapshot
- Symbol
- AFJK
- Price
- $34.02
- Day change
- +0.06%
- Market cap
- $208.3M
- P/E ratio
- 38.45x
- 52-week range
- 6.75-130.37
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
- Bayview Acquisition Corp Class A Ordinary Shares (BAYA)
- Central Plains Bancshares, Inc. Common Stock (CPBI)
- Eureka Acquisition Corp Class A Ordinary Share (EURK)
- Israel Acquisitions Corp (ISRL)
- CSLM Digital Asset Acquisition Corp III Class A Ordinary Shares (KOYN)
- Oak Woods Acquisition Corporation (OAKU)
- Origin Investment Corp I Units (ORIQU)
- Ribbon Acquisition Corp (RIBB)
Recent insider activity
- MIZUHO SECURITIES USA LLC — S-Sale (150000 shares) on 2025-02-11
- MIZUHO SECURITIES USA LLC — trade (0 shares) on 2025-02-10
Open Aimei Health Technology Co., Ltd (AFJK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.